OPKO Health, Inc. (LON:0KCS)
London
· Delayed Price · Currency is GBP · Price in USD 1.739
-0.040 (-2.25%)
Mar 13, 2025, 7:16 PM BST
OPKO Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 713.14 | 863.5 | 1,004 | 1,775 | 1,435 | Upgrade
|
| Revenue Growth (YoY) | -17.41% | -14.01% | -43.42% | 23.64% | 59.15% | Upgrade
|
| Cost of Revenue | 599.85 | 634.96 | 789.86 | 1,270 | 969.72 | Upgrade
|
| Gross Profit | 113.3 | 228.53 | 214.33 | 504.67 | 465.69 | Upgrade
|
| Selling, General & Admin | 304.22 | 300.56 | 372.67 | 468.86 | 355.57 | Upgrade
|
| Operating Expenses | 386.85 | 386.59 | 460.46 | 519.14 | 411.96 | Upgrade
|
| Operating Income | -273.56 | -158.06 | -246.12 | -14.46 | 53.73 | Upgrade
|
| Interest Expense | -47.47 | -13.51 | -12.06 | -18.88 | -21.93 | Upgrade
|
| Interest & Investment Income | 8.43 | 3.98 | 1.98 | 0.03 | 0.15 | Upgrade
|
| Earnings From Equity Investments | -0.02 | -0.11 | -0.38 | -0.63 | -0.48 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.8 | 1.2 | -1.8 | -1.4 | 1.6 | Upgrade
|
| Other Non Operating Income (Expenses) | 164.69 | -18.42 | -149.83 | 3.46 | 11.15 | Upgrade
|
| EBT Excluding Unusual Items | -151.72 | -184.91 | -408.21 | -31.88 | 44.21 | Upgrade
|
| Gain (Loss) on Sale of Investments | 19.85 | -0.56 | -3.57 | -4.87 | 0.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | 121.49 | - | 18.56 | 31.51 | - | Upgrade
|
| Other Unusual Items | - | 1.04 | 1.31 | -9.41 | 3.99 | Upgrade
|
| Pretax Income | -10.38 | -184.43 | -391.9 | -14.65 | 48.2 | Upgrade
|
| Income Tax Expense | 42.84 | 4.44 | -63.5 | 15.49 | 17.62 | Upgrade
|
| Earnings From Continuing Operations | -53.22 | -188.86 | -328.41 | -30.14 | 30.59 | Upgrade
|
| Net Income | -53.22 | -188.86 | -328.41 | -30.14 | 30.59 | Upgrade
|
| Net Income to Common | -53.22 | -188.86 | -328.41 | -30.14 | 30.59 | Upgrade
|
| Shares Outstanding (Basic) | 694 | 752 | 719 | 648 | 641 | Upgrade
|
| Shares Outstanding (Diluted) | 694 | 752 | 719 | 648 | 641 | Upgrade
|
| Shares Change (YoY) | -7.68% | 4.55% | 10.95% | 1.16% | 7.59% | Upgrade
|
| EPS (Basic) | -0.08 | -0.25 | -0.46 | -0.05 | 0.05 | Upgrade
|
| EPS (Diluted) | -0.08 | -0.25 | -0.46 | -0.05 | 0.05 | Upgrade
|
| Free Cash Flow | -208.5 | -44.47 | -119.77 | 6.18 | 5.79 | Upgrade
|
| Free Cash Flow Per Share | -0.30 | -0.06 | -0.17 | 0.01 | 0.01 | Upgrade
|
| Gross Margin | 15.89% | 26.47% | 21.34% | 28.44% | 32.44% | Upgrade
|
| Operating Margin | -38.36% | -18.30% | -24.51% | -0.81% | 3.74% | Upgrade
|
| Profit Margin | -7.46% | -21.87% | -32.70% | -1.70% | 2.13% | Upgrade
|
| Free Cash Flow Margin | -29.24% | -5.15% | -11.93% | 0.35% | 0.40% | Upgrade
|
| EBITDA | -175.38 | -52.76 | -137.47 | 64.26 | 139.09 | Upgrade
|
| EBITDA Margin | -24.59% | -6.11% | -13.69% | 3.62% | 9.69% | Upgrade
|
| D&A For EBITDA | 98.18 | 105.3 | 108.66 | 78.72 | 85.36 | Upgrade
|
| EBIT | -273.56 | -158.06 | -246.12 | -14.46 | 53.73 | Upgrade
|
| EBIT Margin | -38.36% | -18.30% | -24.51% | -0.81% | 3.74% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 36.55% | Upgrade
|
| Revenue as Reported | 713.14 | 863.5 | 1,004 | 1,775 | 1,435 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.